- Thoratec (THOR -1.5%) Q2 results: Product Sales: $118.1M (-9.5%); Gross Profit: $83.8M (-6.4%); Operating Expenses: $58.5M (+3.7%); Operating Income: $25.2M (-23.6%); Net Income: $17.4M (-25.0%); EPS: $0.30 (-25.0%); Quick Assets: $291.2M (-4.8%).
- 2014 Guidance: Revenues: $455M - 470M; GAAP EPS: $0.80 - 0.90; non-GAAP EPS: $1.25 - 1.35.
Check out Seeking Alpha’s new Earnings Center »
From other sites
at Nasdaq.com (Jan 16, 2015)
at Nasdaq.com (Dec 15, 2014)
at Nasdaq.com (Nov 21, 2014)
at CNBC.com (Aug 7, 2014)
at CNBC.com (Nov 15, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs